TRMT6 and hepatocellular carcinoma: In summary, our work provides insights into the dynamic and regulatory role of m1A modification in tRNA underlying hepato-oncogenesis and the potential of TRMT6/TRMT61A as a drug target, which will pave a way to develop more effective therapeutic strategies for HCC patients.